These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20931165)

  • 1. Efficacy and safety of duloxetine in fibromyalgia.
    Ursini F; Pipicelli G; Grembiale RD
    Clin Ter; 2010; 161(4):391-5. PubMed ID: 20931165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of depression in the presence of pain symptoms.
    Mohr P; Bitter I; Svestka J; Seifritz E; Karamustafalioglu O; Koponen H; Sartorius N
    Psychiatr Danub; 2010 Mar; 22(1):4-13. PubMed ID: 20305585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    Perahia DG; Pritchett YL; Desaiah D; Raskin J
    Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia.
    Arnold LM
    Pain Med; 2007 Sep; 8 Suppl 2():S63-74. PubMed ID: 17714117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
    Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
    Mease PJ; Russell IJ; Kajdasz DK; Wiltse CG; Detke MJ; Wohlreich MM; Walker DJ; Chappell AS
    Semin Arthritis Rheum; 2010 Jun; 39(6):454-64. PubMed ID: 19152958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders.
    Gupta S; Nihalani N; Masand P
    Ann Clin Psychiatry; 2007; 19(2):125-32. PubMed ID: 17612852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine for the treatment of fibromyalgia.
    Acuna C
    Drugs Today (Barc); 2008 Oct; 44(10):725-34. PubMed ID: 19137126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants and antiepileptic drugs for chronic non-cancer pain.
    Maizels M; McCarberg B
    Am Fam Physician; 2005 Feb; 71(3):483-90. PubMed ID: 15712623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder.
    Perahia DG; Kajdasz DK; Desaiah D; Haddad PM
    J Affect Disord; 2005 Dec; 89(1-3):207-12. PubMed ID: 16266753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.
    Cowen PJ; Ogilvie AD; Gama J
    Curr Med Res Opin; 2005 Mar; 21(3):345-56. PubMed ID: 15811202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine status.
    Fishbain DA
    Pain Med; 2007 Sep; 8 Suppl 2():S25-6. PubMed ID: 17714112
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
    Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P
    Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant therapy for unexplained symptoms and symptom syndromes.
    O'Malley PG; Jackson JL; Santoro J; Tomkins G; Balden E; Kroenke K
    J Fam Pract; 1999 Dec; 48(12):980-90. PubMed ID: 10628579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine (Cymbalta) for diabetic neuropathic pain.
    Med Lett Drugs Ther; 2005 Aug 15-29; 47(1215-1216):67-8. PubMed ID: 16103866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.
    Leombruni P; Miniotti M; Colonna F; Sica C; Castelli L; Bruzzone M; Parisi S; Fusaro E; Sarzi-Puttini P; Atzeni F; Torta RG
    Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S82-5. PubMed ID: 25786048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging pharmacological therapies for fibromyalgia.
    Lawson K
    Curr Opin Investig Drugs; 2006 Jul; 7(7):631-6. PubMed ID: 16869116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.